After Xigris, researchers look to new targets to combat sepsis

First Page		Document Content
Date: 2012-07-10 13:07:46 Immunosuppressants Immunology Cytokines Drotrecogin alfa Sepsis Septic shock Tumor necrosis factor-alpha Immune system Inflammation Medicine Intensive care medicine Medical emergencies		After Xigris, researchers look to new targets to combat sepsis Add to Reading List Source URL: 211.144.68.84 Download Document from Source Website File Size: 95,83 KB Share Document on Facebook

	Protecting Newborns by Expanding Locally Manufactured QualityAssured Medicines The use of chlorhexidine gel on newborns is effective in preventing life-threatening sepsis and umbilical cord infections. DocID: 1vlUr - View Document
	Hacettepe’de Dünya Sepsis Günü Etkinliği, Basında sıklıkla yer alan yoğun bakımdaki hasta ölümlerinin temel nedenlerinden biri olan sepsis, hem gelişmekte olan hem de gelişmiş ülkelerde sık görülen an DocID: 1vgeY - View Document
	IMPROVING PEDIATRIC SEPSIS OUTCOMES A multi-year collaborative for children’s hospitals to reduce sepsis mortality and morbidity across all levels of care. WHAT’S INSIDE Executive Summary............................. DocID: 1vbKE - View Document
	Frequently Asked Questions  What is IPSO? The IPSO (Improving Pediatric Sepsis Outcomes) is a quality improvement collaborative of children’s hospitals addressing diagnosis and treatment across the hospital. IPSO ai DocID: 1vajS - View Document
	2018 年 5 月 30 放送｢Sepsis-3 における敗血症管理｣名古屋大学大学院救急・集中治療医学教授 DocID: 1v1xA - View Document